Zobrazeno 1 - 8
of 8
pro vyhledávání: '"K V Vimalnath, Nair"'
Autor:
Rahul Krishnatry, Rubel Chakravarty, Haladhar Dev Sarma, K. V. Vimalnath Nair, Venkatesh Rangarajan, K. C. Jagadeesan, Sudipta Chakraborty, A. Rajeswari, Priyalata Shetty
Publikováno v:
Annals of Nuclear Medicine. 34:899-910
Copper-64 is a useful theranostic radioisotope that is attracting renewed interest from the nuclear medicine community in the recent times. This study aims to demonstrate the utility of research reactors to produce clinical-grade 64Cu via 63Cu(n,γ)6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f07b151a48df4ac8836424422ddc6b0
https://doi.org/10.1007/s12149-020-01522-2
https://doi.org/10.1007/s12149-020-01522-2
Autor:
K. V. Vimalnath Nair, Rubel Chakravarty, Haladhar Dev Sarma, Apurav Guleria, Chandan Kumar, Amit Kunwar, Sudipta Chakraborty, Ashutosh Dash
Publikováno v:
Nuclear Medicine and Biology. :1-10
Introduction The emerging concept of intrinsically radiolabeled nanoparticles has the potential to transform the preclinical and clinical studies by improving the in vivo stability and demonstrating minimal alteration in the inherent pharmacokinetics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::feba2a38e78e0f4e3aab7eeb174c9976
https://doi.org/10.1016/j.nucmedbio.2019.05.005
https://doi.org/10.1016/j.nucmedbio.2019.05.005
Autor:
Rubel, Chakravarty, Priyalata, Shetty, K V Vimalnath, Nair, Ardhi, Rajeswari, K C, Jagadeesan, Haladhar Dev, Sarma, Venkatesh, Rangarajan, Rahul, Krishnatry, Sudipta, Chakraborty
Publikováno v:
Annals of nuclear medicine. 34(12)
Copper-64 is a useful theranostic radioisotope that is attracting renewed interest from the nuclear medicine community in the recent times. This study aims to demonstrate the utility of research reactors to produce clinical-gradeCopper-64 was produce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::12d1dce1aaf2e65773e7651476f5a91a
https://pubmed.ncbi.nlm.nih.gov/33048309
https://pubmed.ncbi.nlm.nih.gov/33048309
Autor:
Chandan Kumar, Rakesh Shukla, Sudipta Chakraborty, Ashutosh Dash, K. V. Vimalnath Nair, Rubel Chakravarty, Haladhar Dev Sarma, Avesh K. Tyagi, Apurav Guleria
Publikováno v:
Industrial & Engineering Chemistry Research. 57:14337-14346
The synthesis of intrinsically radiolabeled nanoparticles has shown tremendous prospective in offering an easier, faster, stable, and more specific radiolabeling technique for the development of advanced radionanomedicine agents for cancer treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ab0ac0996ec5e386fbe9064cb6cd6d9
https://doi.org/10.1021/acs.iecr.8b02526
https://doi.org/10.1021/acs.iecr.8b02526
Autor:
Rubel, Chakravarty, Sudipta, Chakraborty, Apurav, Guleria, Chandan, Kumar, Amit, Kunwar, K V Vimalnath, Nair, Haladhar Dev, Sarma, Ashutosh, Dash
Publikováno v:
Nuclear medicine and biology.
The emerging concept of intrinsically radiolabeled nanoparticles has the potential to transform the preclinical and clinical studies by improving the in vivo stability and demonstrating minimal alteration in the inherent pharmacokinetics of the nanop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b6840c3c4670be7b2621d00c5a4d4de5
https://pubmed.ncbi.nlm.nih.gov/31255874
https://pubmed.ncbi.nlm.nih.gov/31255874
Autor:
Amit Kunwar, K. V. Vimalnath Nair, Raghumani Singh Ningthoujam, Rajesh K. Vatsa, Apurav Guleria, Rubel Chakravarty, Haladhar Dev Sarma, K. Shitaljit Sharma, Anand Ballal, Sudipta Chakraborty, Ashutosh Dash
Publikováno v:
Industrial & Engineering Chemistry Research. 55:12407-12419
Synthesis of intrinsically radiolabeled nanoparticles is an emerging concept in cancer theranostics and is expected to play an imperative role in translating nanotechnology research into the nuclear medicine industry. In order to reduce reliance on c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::859b0d6477ac8cc0c0d361a577279fff
https://doi.org/10.1021/acs.iecr.6b03405
https://doi.org/10.1021/acs.iecr.6b03405
Autor:
Rubel Chakravarty, Haladhar Dev Sarma, Sudipta Chakraborty, Ashutosh Dash, K. V. Vimalnath Nair, A. Rajeswari
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 59:354-363
Radiolabelled monoclonal antibodies (mAbs) are increasingly being utilized in cancer theranostics, which is a significant move toward tailored treatment for individual patients. Cetuximab is a recombinant, human-mouse chimeric IgG1 mAb that binds to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a3c9912f0bb22aca462e1dcdc66aefb
https://doi.org/10.1002/jlcr.3413
https://doi.org/10.1002/jlcr.3413
Autor:
Rubel, Chakravarty, Sudipta, Chakraborty, Haladhar Dev, Sarma, K V Vimalnath, Nair, Ardhi, Rajeswari, Ashutosh, Dash
Publikováno v:
Journal of labelled compoundsradiopharmaceuticals. 59(9)
Radiolabelled monoclonal antibodies (mAbs) are increasingly being utilized in cancer theranostics, which is a significant move toward tailored treatment for individual patients. Cetuximab is a recombinant, human-mouse chimeric IgG1 mAb that binds to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::37b469c9c43cf7d4afdbd80248425e9f
https://pubmed.ncbi.nlm.nih.gov/27264196
https://pubmed.ncbi.nlm.nih.gov/27264196